Melanoma has the highest propensity to form brain metastases of all malignancies (39) and given that melanoma patients have a high incidence (10-40%) of developing metastases in the brain (40), the clinical relevance of BRAF mutational status in melanoma brain metastasis has been studied (41, 42). This evidence concerns the gene BRAF and melanoma.